Several studies have attempted to predict the survival of patients with<unk> . In general, nearly 2/3 of patients with<unk><unk>  are alive at 10 years. Important negative prognostic indicators include ascites, encephalopathy, elevated Child-Pugh scores, elevated prothrombin time, and altered serum levels of various substances (sodium, creatinine, albumin, and bilirubin). Survival is also highly dependent on the underlying cause of the<unk> . For example, a patient with an underlying myeloproliferative disorder may progress to acute leukemia, independently of<unk> .
Budd–Chiari syndrome
Hepatic veno-occlusive disease
Liver cancer
Nephrotic syndrome
Alcoholic liver disease
Fatty liver disease
Adams–Oliver syndrome
Hepatopulmonary syndrome